title: Concept of pharmacogenomics and future considerations.
authors.affiliation: Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
authors.forename: Harpreet
authors.initials: H
authors.lastname: Kaur
authors.forename: Sandeep
authors.initials: S
authors.lastname: Grover
authors.forename: Ritushree
authors.initials: R
authors.lastname: Kukreti
mesh_terms: D005544:Forecasting; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods / Q000639:trends*; D011159:Population Surveillance / Q000379:methods
references.citation: Pharmacogenomics J. 2012 Oct;12(5):446-52
references.pmid: 21826086
references.citation: Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):41-66
references.pmid: 21887206
references.citation: Pharmacogenomics. 2008 Oct;9(10):1543-6
references.pmid: 18855540
references.citation: Pharmacogenet Genomics. 2012 Jun;22(6):447-65
references.pmid: 22565165
references.citation: PLoS Comput Biol. 2012;8(12):e1002817
references.pmid: 23300409
references.citation: Curr Opin Biotechnol. 2009 Aug;20(4):429-36
references.pmid: 19733475
references.citation: Clin Pharmacol Ther. 2013 May;93(5):386-7
references.pmid: 23443751
references.citation: Neuropsychopharmacology. 2013 Feb;38(3):377-85
references.pmid: 22990943
references.citation: Genome Med. 2009 Apr 28;1(4):46
references.pmid: 19439031
references.citation: Genomics. 2013 Aug;102(2):131-5
references.pmid: 23402766
references.citation: Blood. 2013 May 23;121(21):4366-76
references.pmid: 23538338
references.citation: Nature. 2009 Nov 12;462(7270):175-81
references.pmid: 19881490
references.citation: Clin Pharmacol Ther. 2009 Jul;86(1):109-13
references.pmid: 19369936
references.citation: Nature. 2011 Feb 24;470(7335):437
references.pmid: 21350443
references.citation: PLoS Comput Biol. 2009 Jul;5(7):e1000423
references.pmid: 19578428